Biogen Inc (BIIB) is trading at $212.50 down 3.77% over the past 24 hours. Its Galaxy Score is 57.1, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 2.6K engagements and 15 posts with 100% positive social sentiment.
AI summary: Biogen Inc. is a biotechnology company focused on Alzheimer's therapies. Price action remains choppy and range-bound as near-term upside is tempered by Apellis dilution concerns and ongoing pricing risk, despite optimism from the growth portfolio and at-home dosing approval.